Tango Therapeutics, Inc.

TNGX XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

3.1B

Short interest (May 15)

22.1%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.65%

↓ 4.4%

Available Shares

↑ 13.8%

Price Chart

Company Overview

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001819133

Asset Type: CS

Market Data

Market Cap: $3,109,931,613

Employees: 137

Status: Active

Short Interest

Current Borrow Fee 0.65%

Range: 0.65% - 0.65%

Available Shares 4M

Range: 3.2M - 4.1M

Recent Changes

Fee Change: ↑ 8.3%

Available Change: ↑ 5.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime